SCHEMBL1079374

SCHEMBL1079374

C[S+]([O-])C=CCN=C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937706 0.79 TRPA1 (0.43)
SCHEMBL994470 0.79 TRPA1 (0.43)
SCHEMBL5000695 0.77 TRPA1 (0.38)
SCHEMBL11382641 0.69
SCHEMBL5575755 0.69
SCHEMBL28596349 0.69 TRPA1 (0.33)
SCHEMBL7073711 0.64
SCHEMBL7073712 0.64
SCHEMBL9686684 0.64
SCHEMBL2551767 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041733-A1 DENTAL CARE COMPOSITION AND METHOD OF PROMOTING CALCIFICATION IN LIVING BODY TISSUE KINJIRUSHI CO., LTD. (JP) 2024-02-08 US claimed
CN-116723826-A Dental care composition and method for promoting calcification of living tissue 金印株式会社 2023-09-08 CN claimed
US-20090326056-A1 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2009-12-31 US claimed
EP-1569628-B1 NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING DSM IP ASSETS BV (NL) 2009-07-22 EP claimed
EP-2020997-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSMIP Assets B.V. (NL) 2009-02-11 EP claimed
WO-2007131767-A2 NOVEL ACTIVES AGAINST PROSTATE CARCINOMA DSM IP ASSETS B.V. (NL) 2007-11-22 WO claimed
US-20060069151-A1 Novel use of lycopene DSM IP ASSETS B.V. (NL) 2006-03-30 US claimed
US-20060020046-A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies DMS IP ASSETS B.V. (NL) 2006-01-26 US claimed
CN-1720030-A The new purposes of lycopene DSM IP ASSETS BV (NL) 2006-01-11 CN claimed
EP-1569628-A1 NOVEL USE OF LYCOPENE DSM IP Assets B.V. (NL) 2005-09-07 EP claimed
CN-1649574-A Compositions comprising lycopene for the treatment and prevention of angiogenesis-related pathologies DSM IP ASSETS BV (NL) 2005-08-03 CN claimed
EP-1476143-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP Assets B.V. (NL) 2004-11-17 EP claimed
WO-2004052351-A1 NOVEL USE OF LYCOPENE DSM IP ASSETS B.V. (CH) 2004-06-24 WO claimed
WO-2003068202-A1 COMPOSITIONS COMPRISING LYCOPENE FOR THE TREATMENT AND PREVENTION OF ANGIOGENESIS ASSOCIATED PATHOLOGIES DSM IP ASSETS B.V. (NL) 2003-08-21 WO claimed
US-6465512-B2 BRINGING THE LEUKEMIC CELLS INTO CONTACT WITH A LEUKEMIC CELL GROWTH INHIBITOR WHICH IS A METHYLSULFINYLALKYL ISOTHIOCYANATE REPRESENTED BY THE GENERAL FORMULA CH3-SO-(CH2)N- N HORIZONTAL-LINE C HORIZONTAL-LINE S NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2002-10-15 US claimed
US-20020022655-A1 Leukemic cell growth inhibiting method NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2002-02-21 US claimed
JP-7247497-A None JP disclosed
US-20240041733-A1 DENTAL CARE COMPOSITION AND METHOD OF PROMOTING CALCIFICATION IN LIVING BODY TISSUE KINJIRUSHI CO., LTD. (JP) 2024-02-08 US disclosed
WO-1999052345-A1 METHOD FOR SELECTIVE INCREASE OF THE ANTICARCINOGENIC GLUCOSINOLATES IN $i(BRASSICA SP.) PLANT BIOSCIENCE LIMITED (GB) 1999-10-21 WO disclosed
JP-H07247497-A PERFUME COMPOSITION OGAWA KORYO KK 1995-09-26 JP disclosed